Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Neurotherapeutics

We’re working on a new version of this journal site - preview it now
Neurotherapeutics

Neurotherapeutics

The Journal of the American Society for Experimental NeuroTherapeutics

Editor-in-Chief: Maral Mouradian

ISSN: 1933-7213 (print version)
ISSN: 1878-7479 (electronic version)

Journal no. 13311

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 4 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

ASENT PB_Banner_A73135_STNL-OC_journal_banners_575x60px
  • Publishes critical reviews of broad interest on the treatment of neurologic disorders by renowned  experts.
  • Covers emerging treatments for neurologic disorders.
  • Publishes cutting edge original translational research in unmet medical needs for diseases of the nervous system.
  • Explores the molecular underpinnings of neurologic diseases as rationale for targeted therapies.
  • Provides a platform for publishing points-of-view by key opinion leaders on current hot topics.

Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. 

The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

Future Theme Issues:

January 2020
Neurobiological Targets in Translational Addiction Research
Guest Editors:  Jesse Schank (U-GA) and Carolina Haas-Koffler (Brown)

April 2020
Neurocritical Care:  Bench to Bedside and Back
Guest Editors:  Claude Hemphill (UCSF) and Michael James (Duke)

July 2020
Aligning New Approaches to Accelerate the Development of Analgesic Therapies
Guest Editors: Christine Sang (Brigham) and William Schmidt (NorthStar Consulting)

October 2020
Therapeutic Advances in Movement Disorders
Guest Editors:  Caroline Tanner and Jill Ostrem (UCSF)

Related subjects » Animal Sciences - Neurology - Neuroscience - Surgery

Impact Factor: 5.552 (2018) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, CSA Neurosciences Abstracts, Current Contents/ Life Sciences, Current Contents/Clinical Medicine, EBSCO Biomedical Reference Collection, EBSCO CINAHL, EBSCO Discovery Service, EBSCO TOC Premier, Gale, Gale Academic OneFile, Gale InfoTrac, Institute of Scientific and Technical Information of China, Japanese Science and Technology Agency (JST), Meta, Naver, OCLC WorldCat Discovery Service, ProQuest Biological Science Database, ProQuest Central, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Medical Database, ProQuest Natural Science Collection, ProQuest Nursing & Allied Health Database, ProQuest Pharma Collection, ProQuest Psychology Database, ProQuest SciTech Premium Collection, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

For authors and editors


  • Journal Citation Reports®
    2018 Impact Factor
  • 5.552
  • Aims and Scope

    Aims and Scope

    Close

    Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. 

    The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

    Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

    Future Theme Issues:

    January 2020
    Neurobiological Targets in Translational Addiction Research
    Guest Editors:  Jesse Schank (U-GA) and Carolina Haas-Koffler (Brown)

    April 2020
    Neurocritical Care:  Bench to Bedside and Back
    Guest Editors:  Claude Hemphill (UCSF) and Michael James (Duke)

    July 2020
    Aligning New Approaches to Accelerate the Development of Analgesic Therapies
    Guest Editors: Christine Sang (Brigham) and William Schmidt (NorthStar Consulting)

    October 2020
    Therapeutic Advances in Movement Disorders
    Guest Editors:  Caroline Tanner and Jill Ostrem (UCSF)

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors (pdf, 200 kB)
  • Conflict of Interest Form (pdf, 494 kB)

Alerts for this journal

 

Get the table of contents of every new issue published in Neurotherapeutics.